Evaluation and clinical application of a quality of life scale for patients with medication-related osteonecrosis of the jaw

Evaluation and clinical application of a quality of life scale for patients with medication-related osteonecrosis of the jaw (MRONJ) - Evaluation and clinical application of a quality of life scale for patients with medication-related osteonecrosis of the jaw (MRONJ)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048986

Enrollment

100

Registered

2022-12-01

Start date

2022-12-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication-Related Osteonecrosis of the Jaw

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with medication-related osteonecrosis of the jaw (MRONJ) at Hiroshima University Hospital

Exclusion criteria

Exclusion criteria: Patients who refused to participate in this study

Design outcomes

Primary

Measure	Time frame
Patient information (basic patient information, risk factors (lifestyle, etc.), treatment history, blood test data before and after treatment, imaging findings, information on underlying disease, and outcome) will be obtained from patient questionnaires and medical records for patients diagnosed with MRONJ. An explanatory questionnaire form (attached) will be distributed to research subjects, and the names of research subjects will be filled in and the data will be tabulated.	—

Measure

Time frame

Patient information (basic patient information, risk factors (lifestyle, etc.), treatment history, blood test data before and after treatment, imaging findings, information on underlying disease, and outcome) will be obtained from patient questionnaires and medical records for patients diagnosed with MRONJ. An explanatory questionnaire form (attached) will be distributed to research subjects, and the names of research subjects will be filled in and the data will be tabulated.

—

Countries

Japan

Contacts

Public ContactSachiko Yamasaki

Hiroshima University Department of Oral Oncology,Graduate School of Biomedical and Health Sciences

sayamasaki@hiroshima-u.ac.jp082-257-5667

Outcome results